SCHEMBL167424

SCHEMBL167424

CC1CC(=O)CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20436910 1.00
Formamide SCHEMBL26614879 0.90
Tert-Butyl Formate SCHEMBL28044015 0.81 TDP1 (0.41)
SCHEMBL28311545 0.76
SCHEMBL10076030 0.75
SCHEMBL13465078 0.75
SCHEMBL21850852 0.74
SCHEMBL22193773 0.74
SCHEMBL9691031 0.73
SCHEMBL5850298 0.73 HTR1A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119875044-A Preparation method and application of super-alkali-resistant bipiperidinium cross-linked anion exchange membrane 宿迁时代储能科技有限公司 2025-04-25 CN claimed
CN-115548397-A Preparation method and application of cross-linked anion exchange membrane 宿迁时代储能科技有限公司 2022-12-30 CN claimed
CN-1125053-C Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R, 5S, 2'R')-3'-hydroxy-2-(2-methoxypropyl)-5,..... BOEHRINGER INGELHEIM KG (DE) 2003-10-22 CN claimed
CN-119875044-A Preparation method and application of super-alkali-resistant bipiperidinium cross-linked anion exchange membrane 宿迁时代储能科技有限公司 2025-04-25 CN disclosed
US-20240124447-A1 INHIBITORS OF THE MENIN-MLL INTERACTION VITAE PHARMACEUTICALS, LLC (US) 2024-04-18 US disclosed
CN-115232129-B PARP1 selective inhibitor and preparation method and application thereof 上海闻耐医药科技有限公司 2023-12-01 CN disclosed
US-11739085-B2 Inhibitors of the menin-MLL interaction VITAE PHARMACEUTICALS, LLC (US) 2023-08-29 US disclosed
CN-114456286-B Catalyst system for olefin polymerization and application thereof 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-114456290-B Catalyst system for olefin polymerization and prepolymerized catalyst composition 中国石油化工股份有限公司 2023-07-21 CN disclosed
US-20230192700-A1 PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12 BAYER AKTIENGESELLSCHAFT (DE) 2023-06-22 US disclosed
EP-4114837-A1 PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12 Bayer Aktiengesellschaft (DE) 2023-01-11 EP disclosed
WO-1997047302-A1 INHIBITION OF SEROTONIN REUPTAKE ELI LILLY AND COMPANY (US) 1997-12-18 WO disclosed
EP-0724570-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011231-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G. D. SEARLE & CO. (US) 1995-04-27 WO disclosed
EP-0094018-B1 4-ARYL-4-PIPERIDINECARBINOLS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-03-09 EP disclosed
EP-0119558-B1 STEREOSELECTIVE REDUCTION OF 2- OR 3-SUBSTITUTED 4-PIPERIDONES WITH SODIUM BOROHYDRIDE HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1987-06-24 EP disclosed
US-4496732-A LOW TEMPERATURE; USING INORGANIC ACID HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1985-01-29 US disclosed
US-4485109-A 4-Aryl-4-piperidinecarbinols E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-11-27 US disclosed
EP-0119558-A1 Stereoselective reduction of 2- or 3-substituted 4-piperidones with sodium borohydride HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1984-09-26 EP disclosed
EP-0094018-A2 4-Aryl-4-piperidinecarbinols E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-11-16 EP disclosed